Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben D Sinisterra

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
AAPS Pharmscitech|March 13, 2009
Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixtureGreice S Borghetti, Ivana S Lula, Ruben D Sinisterra, et al.
Biointerphases|December 3, 2016
KR12 peptide associated with cyclodextrin: Antimicrobial and antitumor activitiesKarina I R Teixeira, Maria E Cortés, Robson A S Santos, et al.
Recent Patents on Biotechnology|February 16, 2021
Impact of DMPEI on Biofilm Adhesion on Latex Urinary CatheterVinícius S Tarabal, Flávia G Silva, Ruben D Sinisterra, et al.
Biomaterials|March 17, 2004
A novel polymeric chlorhexidine delivery device for the treatment of periodontal diseaseIsaac C Yue, Jason Poff, María E Cortés, et al.
Clinics (Sao Paulo, Brazil)|July 27, 2011
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effectRodrigo Araujo Fraga-Silva, Fabiana P Costa-Fraga, Frederico B De Sousa, et al.
Cell and Tissue Research|January 13, 2019
Testosterone improves the osteogenic potential of a composite in vitro and in vivoKelen J R da Costa, Alfonso Gala-García, Joel J Passos, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasisCynthia Demicheli, Rosemary Ochoa, José B B da Silva, et al.
Drug Development and Industrial Pharmacy|April 24, 2018
A long-lasting oral preformulation of the angiotensin II AT1 receptor antagonist losartanWashington X De Paula, Ângelo M L Denadai, Aline N G Braga, et al.
The Journal of Sexual Medicine|July 30, 2013
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemiaRodrigo A Fraga-Silva, Fabiana P Costa-Fraga, Silvia Q Savergnini, et al.
World Journal of Microbiology & Biotechnology|November 6, 2023
Effect of DMPEI coating against biofilm formation on PVC catheter surfaceVinícius S Tarabal, Yuri K D Abud, Flávia G da Silva, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
AAPS Pharmscitech|March 13, 2009
Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixtureGreice S Borghetti, Ivana S Lula, Ruben D Sinisterra, et al.
Biointerphases|December 3, 2016
KR12 peptide associated with cyclodextrin: Antimicrobial and antitumor activitiesKarina I R Teixeira, Maria E Cortés, Robson A S Santos, et al.
Recent Patents on Biotechnology|February 16, 2021
Impact of DMPEI on Biofilm Adhesion on Latex Urinary CatheterVinícius S Tarabal, Flávia G Silva, Ruben D Sinisterra, et al.
Biomaterials|March 17, 2004
A novel polymeric chlorhexidine delivery device for the treatment of periodontal diseaseIsaac C Yue, Jason Poff, María E Cortés, et al.
Clinics (Sao Paulo, Brazil)|July 27, 2011
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effectRodrigo Araujo Fraga-Silva, Fabiana P Costa-Fraga, Frederico B De Sousa, et al.
Cell and Tissue Research|January 13, 2019
Testosterone improves the osteogenic potential of a composite in vitro and in vivoKelen J R da Costa, Alfonso Gala-García, Joel J Passos, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasisCynthia Demicheli, Rosemary Ochoa, José B B da Silva, et al.
Drug Development and Industrial Pharmacy|April 24, 2018
A long-lasting oral preformulation of the angiotensin II AT1 receptor antagonist losartanWashington X De Paula, Ângelo M L Denadai, Aline N G Braga, et al.
The Journal of Sexual Medicine|July 30, 2013
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemiaRodrigo A Fraga-Silva, Fabiana P Costa-Fraga, Silvia Q Savergnini, et al.
World Journal of Microbiology & Biotechnology|November 6, 2023
Effect of DMPEI coating against biofilm formation on PVC catheter surfaceVinícius S Tarabal, Yuri K D Abud, Flávia G da Silva, et al.
Pageof 2